These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26140252)

  • 1. Epstein-Barr virus-induced gene 3-deficiency leads to impaired antitumor T-cell responses and accelerated tumor growth.
    Liu Z; Liu JQ; Shi Y; Zhu X; Liu Z; Li MS; Yu J; Wu LC; He Y; Zhang G; Bai XF
    Oncoimmunology; 2015 Jul; 4(7):e989137. PubMed ID: 26140252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus-Induced Gene 3 (EBI3) Blocking Leads to Induce Antitumor Cytotoxic T Lymphocyte Response and Suppress Tumor Growth in Colorectal Cancer by Bidirectional Reciprocal-Regulation STAT3 Signaling Pathway.
    Liang Y; Chen Q; Du W; Chen C; Li F; Yang J; Peng J; Kang D; Lin B; Chai X; Zhou K; Zeng J
    Mediators Inflamm; 2016; 2016():3214105. PubMed ID: 27247488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Th17 and regulatory T cell responses in EBV-induced gene 3-deficient mice lead to marginally enhanced development of autoimmune encephalomyelitis.
    Liu JQ; Liu Z; Zhang X; Shi Y; Talebian F; Carl JW; Yu C; Shi FD; Whitacre CC; Trgovcich J; Bai XF
    J Immunol; 2012 Apr; 188(7):3099-106. PubMed ID: 22387555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disruption of T helper 2-immune responses in Epstein-Barr virus-induced gene 3-deficient mice.
    Nieuwenhuis EE; Neurath MF; Corazza N; Iijima H; Trgovcich J; Wirtz S; Glickman J; Bailey D; Yoshida M; Galle PR; Kronenberg M; Birkenbach M; Blumberg RS
    Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16951-6. PubMed ID: 12482940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus-induced gene 3 suppresses T helper type 1, type 17 and type 2 immune responses after Trypanosoma cruzi infection and inhibits parasite replication by interfering with alternative macrophage activation.
    Böhme J; Roßnagel C; Jacobs T; Behrends J; Hölscher C; Erdmann H
    Immunology; 2016 Mar; 147(3):338-48. PubMed ID: 26694585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t.
    Yang J; Yang M; Htut TM; Ouyang X; Hanidu A; Li X; Sellati R; Jiang H; Zhang S; Li H; Zhao J; Ting AT; Mayer L; Unkeless JC; Labadia ME; Hodge M; Li J; Xiong H
    Eur J Immunol; 2008 May; 38(5):1204-14. PubMed ID: 18412165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis.
    Wirtz S; Billmeier U; Mchedlidze T; Blumberg RS; Neurath MF
    Gastroenterology; 2011 Nov; 141(5):1875-86. PubMed ID: 21820391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Th1 responses in mice deficient in Epstein-Barr virus-induced gene 3 and challenged with physiological doses of Leishmania major.
    Zahn S; Wirtz S; Birkenbach M; Blumberg RS; Neurath MF; von Stebut E
    Eur J Immunol; 2005 Apr; 35(4):1106-12. PubMed ID: 15756639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-10 enhances CTL-mediated tumor rejection by inhibiting highly suppressive CD4
    Wang L; Liu JQ; Talebian F; Liu Z; Yu L; Bai XF
    Oncoimmunology; 2015 Jul; 4(7):e1014232. PubMed ID: 26140236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human CD4+ CD25+ Foxp3+ regulatory T cells do not constitutively express IL-35.
    Bardel E; Larousserie F; Charlot-Rabiega P; Coulomb-L'Herminé A; Devergne O
    J Immunol; 2008 Nov; 181(10):6898-905. PubMed ID: 18981109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated Tregs obstruct antitumor immunity by promoting T cell dysfunction and restricting clonal diversity in tumor-infiltrating CD8+ T cells.
    Noyes D; Bag A; Oseni S; Semidey-Hurtado J; Cen L; Sarnaik AA; Sondak VK; Adeegbe D
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35618289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor gene-engineered J558 tumor cell-released exosomes stimulate tumor antigen P1A-specific CD8+ CTL responses and antitumor immunity.
    Xie Y; Bai O; Zhang H; Li W; Xiang J
    Cancer Biother Radiopharm; 2010 Feb; 25(1):21-8. PubMed ID: 20187793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance.
    Sullivan JA; Tomita Y; Jankowska-Gan E; Lema DA; Arvedson MP; Nair A; Bracamonte-Baran W; Zhou Y; Meyer KK; Zhong W; Sawant DV; Szymczak-Workman AL; Zhang Q; Workman CJ; Hong S; Vignali DAA; Burlingham WJ
    Cell Rep; 2020 Jan; 30(4):1039-1051.e5. PubMed ID: 31995748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer.
    Nagai H; Horikawa T; Hara I; Fukunaga A; Oniki S; Oka M; Nishigori C; Ichihashi M
    Exp Dermatol; 2004 Oct; 13(10):613-20. PubMed ID: 15447721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals.
    Chiyo M; Shimozato O; Yu L; Kawamura K; Iizasa T; Fujisawa T; Tagawa M
    Int J Cancer; 2005 Jun; 115(3):437-42. PubMed ID: 15688376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.
    Wang Z; Liu JQ; Liu Z; Shen R; Zhang G; Xu J; Basu S; Feng Y; Bai XF
    J Immunol; 2013 Mar; 190(5):2415-23. PubMed ID: 23345334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous IL-33 exerts CD8
    Xia Y; Ohno T; Nishii N; Bhingare A; Tachinami H; Kashima Y; Nagai S; Saito H; Nakae S; Azuma M
    Biochem Biophys Res Commun; 2019 Oct; 518(2):331-336. PubMed ID: 31421832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebi3 promotes T- and B-cell division and differentiation via STAT3.
    Ma N; Fang Y; Xu R; Zhai B; Hou C; Wang X; Jiang Z; Wang L; Liu Q; Han G; Wang R
    Mol Immunol; 2019 Mar; 107():61-70. PubMed ID: 30660991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased expression of EBI3 and Foxp3 in CD4+CD25+ regulatory T cells in murine experimental allergic rhinitis.
    Ouyang Y; Nakao A; Fan E; Li Y; Zhao L; Zhang W; Han D; Zhang L
    ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):313-20. PubMed ID: 21986066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12p35 Deficiency Reverses the Th1/Th2 Imbalance, Aggravates the Th17/Treg Imbalance, and Ameliorates Atherosclerosis in ApoE-/- Mice.
    Huang Y; Hu H; Liu L; Ye J; Wang Z; Que B; Liu W; Shi Y; Zeng T; Shi L; Ji Q; Chang C; Lin Y
    Mediators Inflamm; 2019; 2019():3152040. PubMed ID: 31093011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.